Profil
Mr. Constantine Chinoporos is on the Board of Directors at Geron Corp.
and Halozyme Hypercon, Inc. Mr. Chinoporos was previously employed as a Chief Operating & Business Officer by Applied Therapeutics, Inc., a Chief Business Officer by Albireo Pharma, Inc., a Chief Business Officer by Boston Pharmaceuticals, Inc., and a Head-Corporate Development by Genzyme Corp.
He received his undergraduate degree from Cornell University and an MBA from Johnson Graduate School of Management.
Aktive Positionen von Constantine Chinoporos
| Unternehmen | Position | Beginn |
|---|---|---|
| GERON CORPORATION | Direktor/Vorstandsmitglied | 25.03.2026 |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Constantine Chinoporos
| Unternehmen | Position | Ende |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Geschäftsführer | 03.02.2026 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01.03.2023 |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Corporate Officer/Principal | 01.10.2021 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
Ausbildung von Constantine Chinoporos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Applied Therapeutics, Inc.
Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Elektrofi, Inc.
Elektrofi, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company with a breakthrough ultra-high concentration microparticle technology for biologics | Commercial Services |
















